| Entry |
|
|---|
| Name |
Netarsudil mesylate (USAN);
Rhopressa (TN) |
|---|
| Product |
|
|---|
| Formula |
C28H27N3O3. (CH4SO3)2
|
|---|
| Exact mass |
645.1815
|
|---|
| Mol weight |
645.7436
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG02692): | D11031<US> |
| Product (mixture): | D11558<US> |
|
|---|
| Efficacy |
Antiglaucoma, Rho-associated kinase inhibitor |
|---|
| Disease |
Open-angle glaucoma [DS: H00612] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EX Other antiglaucoma preparations
S01EX05 Netarsudil
D11031 Netarsudil mesylate (USAN) <US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Intraocular Pressure Lowering Agents
Netarsudil
D11031 Netarsudil mesylate (USAN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
AGC group
ROCK
D11031 Netarsudil mesylate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11031
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11031
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11031
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 44
1 C8x C 10.2929 -15.4754
2 N5x N 10.2929 -16.8759
3 C8x C 11.5533 -17.5762
4 C8y C 12.7437 -16.8759
5 C8y C 12.7437 -15.4754
6 C8x C 11.5533 -14.7752
7 C8x C 13.9341 -17.5762
8 C8x C 15.1946 -16.8759
9 C8y C 15.1946 -15.4754
10 C8x C 13.9341 -14.7752
11 N1b N 16.3850 -14.7752
12 C5a C 17.5754 -15.4754
13 C1c C 18.7658 -14.7752
14 C8y C 19.9562 -15.4754
15 O5a O 17.5754 -16.8759
16 C1b C 18.7658 -13.3747
17 N1a N 19.9562 -12.6745
18 C8x C 19.9562 -16.8759
19 C8x C 21.1466 -17.5762
20 C8y C 22.4071 -16.8759
21 C8x C 22.4071 -15.4754
22 C8x C 21.1466 -14.7752
23 C1b C 23.5975 -17.5762
24 O7a O 24.7879 -16.8759
25 C7a C 25.9783 -17.5762
26 C8y C 27.1687 -16.8759
27 O6a O 25.9783 -18.9766
28 C8y C 28.4291 -17.5762
29 C8x C 29.6195 -16.8759
30 C8y C 29.6195 -15.4754
31 C8x C 28.4291 -14.7752
32 C8x C 27.1687 -15.4754
33 C1a C 28.4291 -18.9766
34 C1a C 30.8099 -14.7752
35 S4a S 36.2600 -16.4500
36 O1d O 34.8600 -16.4500
37 C1a C 37.6600 -16.4500
38 O1d O 36.2600 -15.0500
39 O1d O 36.2600 -17.8500
40 S4a S 36.2600 -16.4500
41 O1d O 34.8600 -16.4500
42 C1a C 37.6600 -16.4500
43 O1d O 36.2600 -15.0500
44 O1d O 36.2600 -17.8500
BOND 45
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 12 15 2
17 13 16 1 #Down
18 16 17 1
19 14 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 14 22 1
25 20 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 25 27 2
30 26 28 2
31 28 29 1
32 29 30 2
33 30 31 1
34 31 32 2
35 26 32 1
36 28 33 1
37 30 34 1
38 35 36 1
39 35 37 1
40 35 38 2
41 35 39 2
42 40 41 1
43 40 42 1
44 40 43 2
45 40 44 2
BRACKET 1 33.1100 -18.6900 33.1100 -14.2100
1 39.4100 -14.2100 39.4100 -18.6900
1 2
ORIGINAL 1 35 36 37 38 39
REPEAT 1 40 41 42 43 44
|
|---|
